by Stephen Manobiano | Oct 7, 2026 | Automation, Commercialization, CRM best practices, Data Management, Founders and Business Leaders, HubSpot, Insight
12 Questions Life Science Founders, CEOs, and Commercial Leaders Ask When Choosing a CRM for a Product or Service Company Most “best life sciences CRM” lists are written for global pharma: field forces calling on physicians, regulated sample distribution, and...
by Matthew Manobianco | Sep 10, 2026 | Commercialization, CRM best practices, HubSpot, news
Choosing a CRM is only the first step. The more important question is whether the system will be designed, implemented, and managed around the way your life sciences company actually operates. Biotech companies, CROs, CDMOs, research-tool manufacturers, reagent...
by Matthew Manobianco | Sep 4, 2026 | CRM best practices, HubSpot, Insight
What to evaluate when your commercial model runs on both direct and distributor sales, as well as a long, scientific buying cycle.Choosing a CRM is one of the highest-leverage commercial decisions an early biotech makes, and one of the easiest to get wrong because...
by Stephen Manobiano | Sep 3, 2026 | CRM best practices, HubSpot, Insight
A practical guide to evaluating CRM implementation partners for complex scientific sales cycles, including strategy, integration, and the part everyone underestimates: adoption. Most life sciences companies choosing a CRM partner end up talking to a marketing agency....
by Stephen Manobiano | Jul 1, 2026 | business development, Commercialization, CRM best practices, Data Management, Founders and Business Leaders, Fractional, Marketing, news, Sales
NGS isn’t “next gen” anymore. The core sequencing instrument market is dominated by a small number of established platform vendors, and that’s not changing. If your growth strategy still depends on competing for that instrument-level attention, you’re...
by Stephen Manobiano | Jul 1, 2026 | Automation, business development, Commercialization, CRM best practices, Data Management, Founders and Business Leaders, news, Sales
Labs are getting smaller, more automated, and more distributed. Instruments are shrinking and handling more of the manual work themselves. Research hubs outside the traditional life science centers are standing up modular, flexible labs instead of building large...
